RGEN (RGEN) Stock Price & Analysis
RGEN (RGEN) fell 1.19% to USD 167.6 as of September 8, 2026 at 07:36 UTC, according to Nexqual real-time market data.
RGEN last closed at USD 167.6; the session ranged USD 165–169.5 on volume of 806,066 shares. Market capitalization is —, with a 52-week range of USD 100.99–188.73 (NMS). Source: Nexqual, September 8, 2026 at 07:36 UTC.
Key Statistics (as of September 8, 2026 at 07:36 UTC)
| Price | USD 167.6 |
|---|---|
| Change | ▼ 1.19% (down) |
| Previous Close | USD 167.6 |
| Open | USD 167.6 |
| Day Range | USD 165 – 169.5 |
| 52-Week Range | USD 100.99 – 188.73 |
| Volume | 806,066 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (RGEN)
Nexqual's technical model rates RGEN "BUY" based on 4 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 07:36 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 52.16 (neutral) |
| vs SMA50 | Above (USD 155.63) |
| MACD | 5.25 (positive) |
From RGEN's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NBIX | Neurocrine Biosciences, Inc. | USD 155.64 | ▼ 1.36% |
| QDEL | QuidelOrtho Corporation | USD 13.97 | ▲ 0.14% |
| NVCR | NovoCure Limited | USD 17.94 | ▲ 0.62% |
| PODD | Insulet Corporation | USD 147.48 | ▼ 0.45% |
| STAA | STAAR Surgical Company | USD 23.47 | ▲ 1.56% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:36 UTC. This page is informational and not investment advice.